BCAB
Bioatla IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.10M
P/E Ratio
—
EPS
$-25.07
Beta
0.76
52W High
$71.50
52W Low
$2.81
50-Day MA
$3.63
200-Day MA
$14.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bioatla Inc
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $8.50M |
| Gross Profit (TTM) | $-34.57M |
| EBITDA | $-31.33M |
| Operating Margin | 3.49% |
| Return on Equity | -814.00% |
| Return on Assets | -107.60% |
| Revenue/Share (TTM) | $6.14 |
| Book Value | $-22.48 |
| Price-to-Book | 2.68 |
| Price-to-Sales (TTM) | 0.60 |
| EV/Revenue | 1.108 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 31.60% |
| Shares Outstanding | $1.67M |
| Float | $1.38M |
| % Insiders | 5.44% |
| % Institutions | 21.37% |
Historical Volatility
HV 10-Day
66.57%
HV 20-Day
68.94%
HV 30-Day
81.72%
HV 60-Day
82.00%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BCAB and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026